Mirum Pharmaceuticals, Inc. (MIRM)
95.21
-1.19
(-1.23%)
USD |
NASDAQ |
Apr 16, 12:30
Mirum Pharmaceuticals Research and Development Expense (Quarterly) : 51.03M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 116.42M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Insmed, Inc. | 254.91M |
| Ionis Pharmaceuticals, Inc. | 279.36M |
| Cogent Biosciences, Inc. | 74.38M |